Literature DB >> 1705575

Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistry.

S Chokroverty1, W Nicklas, D C Miller, J Goldberg, J Choe, C Banner, J Thomas, R Duvoisin.   

Abstract

The neuropathological findings in a patient with antemortem diagnosis of olivopontocerebellar atrophy (OPCA) and reduced leucocytic glutamate dehydrogenase (GDH) activity included cerebellar cortical degeneration, most marked in the superior vermis, mild atrophy of the pons and the inferior olivary nucleus, marked reduction of anterior horn cells at all levels and gliosis in both lateral columns. GDH activities and their thermolability in "soluble" and "particulate" fractions in the cerebral cortex, cerebellar hemisphere and vermis were not significantly different from the values in two control brains. GDH mRNA in the patient's brain was not altered in size or amount.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705575      PMCID: PMC488324          DOI: 10.1136/jnnp.53.12.1099

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis.

Authors:  J C Parker; M L Dyer; W A Paulsen
Journal:  J Clin Neuroophthalmol       Date:  1987-12

2.  Clinical expression of glutamate dehydrogenase deficiency.

Authors:  R C Duvoisin; S Chokroverty
Journal:  Adv Neurol       Date:  1984

3.  Glutamate dehydrogenase and its isozyme activity in olivopontocerebellar atrophy.

Authors:  Y Konagaya; M Konagaya; T Takayanagi
Journal:  J Neurol Sci       Date:  1986-07       Impact factor: 3.181

4.  Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces gamma-aminobutyric acid.

Authors:  D L Kaufman; J F McGinnis; N R Krieger; A J Tobin
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

5.  Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.

Authors:  B H Westerink; M H Tuinte
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

6.  Isolation of a human brain cDNA for glutamate dehydrogenase.

Authors:  C Banner; S Silverman; J W Thomas; K A Lampel; L Vitkovic; D Huie; R J Wenthold
Journal:  J Neurochem       Date:  1987-07       Impact factor: 5.372

7.  Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy.

Authors:  A Grossman; R N Rosenberg; L Warmoth
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

8.  Pathology of olivopontocerebellar atrophy with glutamate dehydrogenase deficiency.

Authors:  S Chokroverty; R Khedekar; B Derby; R Sachdeo; C Yook; F Lepore; W Nicklas; R C Duvoisin
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

9.  Glutamate dehydrogenase in olivopontocerebellar atrophies: leukocytes, fibroblasts, and muscle mitochondria.

Authors:  G Finocchiaro; F Taroni; S Di Donato
Journal:  Neurology       Date:  1986-04       Impact factor: 9.910

10.  Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy.

Authors:  S Sorbi; S Tonini; E Giannini; S Piacentini; P Marini; L Amaducci
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.